Skip to main content
Top
Published in:

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Association of insulin resistance with chronic kidney disease in individuals without diabetes in a community population in South China

Authors: Jiamin Li, Qin Zhou, Zhen Liu, Hequn Zou

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

To explore the relationship of insulin resistance (IR) with chronic kidney disease (CKD) in individuals without diabetes.

Methods

We performed a cross-sectional survey among 2142 community-based participants without diabetes from southern China from June to October 2012 and excluded the incomplete data. We divided all the participants into four groups according to the quartiles of homeostasis model assessment of IR (HOMA-IR). Logistic regression models were used to explore the associations of IR with CKD in these subjects.

Results

In the unadjusted model, compared with the quartile one group, IR was significantly associated with CKD (odds ratio [OR] = 2.24, P < 0.001; OR = 4.46, P < 0.001) in the quartile three and four groups, and the association was still significant (OR = 2.08, P = 0.005; OR = 3.89, P < 0.001 ) after adjusting for potential confounders (including age, current smoker, current alcohol use, physical inactivity, education level, systolic blood pressure, diastolic blood pressure, serum triglyceride, and body mass index). The area under the receiver operating characteristic curve (95% confidence interval) of HOMA-IR for diagnosing CKD was 0.67 (0.64, 0.71). The cut-off value was 2.5, the sensitivity was 75.2%, and the specificity was 56.4%.

Conclusions

IR is associated with Chronic Kidney Disease (CKD) in participants without diabetes. It has been proposed that CKD patients may benefit from reducing their insulin resistance.
Literature
1.
go back to reference Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and end-stage renal Disease. Semin Nephrol. 2016;36(4):319–30.CrossRefPubMed Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and end-stage renal Disease. Semin Nephrol. 2016;36(4):319–30.CrossRefPubMed
2.
go back to reference Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10(2):e97-185. Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10(2):e97-185.
3.
go back to reference Jung SH, Jung CH, Reaven GM, Kim SH. Adapting to insulin resistance in obesity: role of insulin secretion and clearance. Diabetologia. 2018;61(3):681–7.CrossRefPubMed Jung SH, Jung CH, Reaven GM, Kim SH. Adapting to insulin resistance in obesity: role of insulin secretion and clearance. Diabetologia. 2018;61(3):681–7.CrossRefPubMed
4.
go back to reference Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14(2):469–77.CrossRefPubMed Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14(2):469–77.CrossRefPubMed
5.
go back to reference Conkar S, Mir S. Relationship of insulin resistance to vitamin d status in children with nondiabetic chronic kidney disease. Saudi J Kidney Dis Transpl. 2017;28(5):1078–84.CrossRefPubMed Conkar S, Mir S. Relationship of insulin resistance to vitamin d status in children with nondiabetic chronic kidney disease. Saudi J Kidney Dis Transpl. 2017;28(5):1078–84.CrossRefPubMed
6.
go back to reference Wakino S, Minakuchi H, Miya K, Takamatsu N, Tada H, Tani E, et al. Aldosterone and insulin resistance: vicious combination in patients on maintenance Hemodialysis. Ther Apher Dial. 2018;22(2):142–51.CrossRefPubMed Wakino S, Minakuchi H, Miya K, Takamatsu N, Tada H, Tani E, et al. Aldosterone and insulin resistance: vicious combination in patients on maintenance Hemodialysis. Ther Apher Dial. 2018;22(2):142–51.CrossRefPubMed
7.
go back to reference Kumar BV, Mohan T. Retrospective comparison of estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 Hour urine creatinine Clearance. J Clin Diagn Res. 2017;11(5):C9–12. Kumar BV, Mohan T. Retrospective comparison of estimated GFR using 2006 MDRD, 2009 CKD-EPI and Cockcroft-Gault with 24 Hour urine creatinine Clearance. J Clin Diagn Res. 2017;11(5):C9–12.
8.
go back to reference de Boer IH, Zelnick L, Afkarian M, Ayers E, Curtin L, Himmelfarb J, et al. Impaired glucose and insulin homeostasis in moderate-severe CKD. J Am Soc Nephrol. 2016;27(9):2861–71.CrossRefPubMedPubMedCentral de Boer IH, Zelnick L, Afkarian M, Ayers E, Curtin L, Himmelfarb J, et al. Impaired glucose and insulin homeostasis in moderate-severe CKD. J Am Soc Nephrol. 2016;27(9):2861–71.CrossRefPubMedPubMedCentral
9.
go back to reference Cao W, Shi M, Wu L, Yang Z, Yang X, Liu H, et al. A renal-cerebral-peripheral sympathetic reflex mediates insulin resistance in chronic kidney disease. EBioMedicine. 2018;37:281–93.CrossRefPubMedPubMedCentral Cao W, Shi M, Wu L, Yang Z, Yang X, Liu H, et al. A renal-cerebral-peripheral sympathetic reflex mediates insulin resistance in chronic kidney disease. EBioMedicine. 2018;37:281–93.CrossRefPubMedPubMedCentral
10.
go back to reference Xu H, Carrero JJ. Insulin resistance in chronic kidney disease. Nephrol (Carlton). 2017;22 Suppl 4:31 – 4. Xu H, Carrero JJ. Insulin resistance in chronic kidney disease. Nephrol (Carlton). 2017;22 Suppl 4:31 – 4.
11.
go back to reference Juszczak F, Caron N, Mathew AV, Declèves AE. Critical role for AMPK in Metabolic Disease-Induced chronic kidney Disease. Int J Mol Sci. 2020;21(21):7994.CrossRefPubMedPubMedCentral Juszczak F, Caron N, Mathew AV, Declèves AE. Critical role for AMPK in Metabolic Disease-Induced chronic kidney Disease. Int J Mol Sci. 2020;21(21):7994.CrossRefPubMedPubMedCentral
12.
go back to reference Guthoff M, Wagner R, Vosseler D, Peter A, Nadalin S, Häring HU, et al. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis. Nephrol Dial Transpl. 2017;32(4):670–6.CrossRef Guthoff M, Wagner R, Vosseler D, Peter A, Nadalin S, Häring HU, et al. Impact of end-stage renal disease on glucose metabolism-a matched cohort analysis. Nephrol Dial Transpl. 2017;32(4):670–6.CrossRef
13.
go back to reference Tan Z, Ye Z, Zhang J, Chen Y, Cheng C, Wang C, et al. Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients. PLoS ONE. 2017;12(4):e176137.CrossRef Tan Z, Ye Z, Zhang J, Chen Y, Cheng C, Wang C, et al. Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients. PLoS ONE. 2017;12(4):e176137.CrossRef
14.
go back to reference Tahar A, Zerdoumi F, Saidani M, Griene L, Koceir EA. [Effects of oral vitamin D(3) supplementation in stage 3 chronic kidney disease subjects: insulin resistance syndrome and hormonal disturb interactions]. Ann Biol Clin (Paris). 2018;76(3):313–25.PubMed Tahar A, Zerdoumi F, Saidani M, Griene L, Koceir EA. [Effects of oral vitamin D(3) supplementation in stage 3 chronic kidney disease subjects: insulin resistance syndrome and hormonal disturb interactions]. Ann Biol Clin (Paris). 2018;76(3):313–25.PubMed
15.
go back to reference Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, et al. Chronic kidney disease attenuates the plasma metabolome response to insulin. JCI Insight. 2018;3(16):e122219.CrossRefPubMedPubMedCentral Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, et al. Chronic kidney disease attenuates the plasma metabolome response to insulin. JCI Insight. 2018;3(16):e122219.CrossRefPubMedPubMedCentral
16.
go back to reference Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219–32.CrossRefPubMed Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, et al. Association of the metabolic syndrome with mortality and major adverse cardiac events: a large chronic kidney disease cohort. J Intern Med. 2021;290(6):1219–32.CrossRefPubMed
17.
go back to reference Chalupsky M, Goodson DA, Gamboa JL, Roshanravan B. New insights into muscle function in chronic kidney disease and metabolic acidosis. Curr Opin Nephrol Hypertens. 2021;30(3):369–76.CrossRefPubMed Chalupsky M, Goodson DA, Gamboa JL, Roshanravan B. New insights into muscle function in chronic kidney disease and metabolic acidosis. Curr Opin Nephrol Hypertens. 2021;30(3):369–76.CrossRefPubMed
18.
go back to reference Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A, et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transpl. 2011;26(9):2814–19.CrossRef Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A, et al. Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transpl. 2011;26(9):2814–19.CrossRef
19.
go back to reference Wang CJ, Bao XR, Du GW, Wang Y, Chen K, Shen ML, et al. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1–3. Int Urol Nephrol. 2014;46(8):1609–17.CrossRefPubMedPubMedCentral Wang CJ, Bao XR, Du GW, Wang Y, Chen K, Shen ML, et al. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1–3. Int Urol Nephrol. 2014;46(8):1609–17.CrossRefPubMedPubMedCentral
20.
go back to reference Johns BR, Pao AC, Kim SH. Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transpl. 2012;27(4):1410–5.CrossRef Johns BR, Pao AC, Kim SH. Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals. Nephrol Dial Transpl. 2012;27(4):1410–5.CrossRef
Metadata
Title
Association of insulin resistance with chronic kidney disease in individuals without diabetes in a community population in South China
Authors
Jiamin Li
Qin Zhou
Zhen Liu
Hequn Zou
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03866-7

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more